Kestra Medical Technologies, Ltd.

kestramedical.com

What Do They Do?

Provides wearable defibrillators and connected monitoring and care-support tools for patients at elevated risk of sudden cardiac arrest and the clinicians managing their recovery.

How Do They Make Money?

Kestra leases its ASSURE system to patients for a fixed amount month to month, billing third-party payors and patients for co-payments or other uncovered costs.

FY2026 revenue

Who Are Their Customers?

Cardiologists, electrophysiologists and other providers at hospitals and clinics prescribe the ASSURE WCD to patients, and Kestra's direct sales force targets these providers. Contracted patient specialists fit and train patients after a prescription.

Do Revenues Turn Into Profits?

No. It lost $131.6M in FY2026.

Operating income, FY2026

−142% of revenue

▲ +27% (Loss) vs FY2025 (−$106.4M, −178%)

Net income, FY2026

−138% of revenue

▲ +16% (Loss) vs FY2025 (−$113.8M, −190%)

Free cash flow, FY2026

−123% of revenue

▲ +16% (Loss) vs FY2025 (−$100.5M, −168%)

How Are They Changing?

Since the FY2026 annual report

Latest quarter: Q1 FY2026, the three months to Jul 31, 2026

Revenue: ▲ +60%; vs $19.4M in Q1 FY2025
Net income: ▲ +71% (Loss); vs −$25.8M in Q1 FY2025

Sep 14, 2026 Raised full-year revenue guidance to $141 million The forecast increased from $137 million.

Who Do They Compete With?

Competes with ZOLL Medical

Comments